Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00933543 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)
A Phase 2 study of Acne Vulgaris, sponsored by Photocure.
- Completed
- Registry status
- Phase 2
- Development phase
- 107
- Enrollment target
- 11
- Study locations
NCT00933543 is a Phase 2 study of Acne Vulgaris that has completed, run by Photocure. The registered enrollment target is 107 participants, below the 274-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (61% lower). The trial reports 11 study locations across 9 states.
The verdict
NCT00933543, a Phase 2 study of Acne Vulgaris, has completed, sponsored by Photocure.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 107 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this trial is to study the efficacy and safety of Visonac PDT in patients from 9 to 35 years old with Aktilite® CL512. Patients was randomized to Visonac or vehicle cream without occlusion and red light(dose: 37J/cm2)
Conditions Studied
Interventions
- PROCEDURE PDT
- DRUG Visonac PDT (MAL PDT)
- DRUG Vehicle cream (placebo)
Study Locations (11)
Illinois
- DeNova Research - Chicago
- Dermatology Institute of DuPage Medical Group - Naperville
Quebec
- INNOVADERM Research Inc. - Montreal
- Centre de Recherche Dermatologique - Québec
California
- Children's Specialists of San Diego / Rady Children's Hospital San Diego - San Diego
Minnesota
- Minnesota Clinical Study Center - Fridley
New York
- Dermatology Associates of Rochester - Rochester
Pennsylvania
- Milton S. Hershey Medical Center - Hershey
Virginia
- Virginia Clinical Research, Inc. - Norfolk
Wisconsin
- Madison Skin & Research, Inc - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00933543
The ClinicalTrials.gov registry entry for NCT00933543 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 274-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (61% lower). The listed sponsor is Photocure, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 3 interventions - of which PDT is the first listed.
NCT00933543 reports 11 study locations spanning 9 distinct geographic areas - top geographies include Illinois, Quebec, California.
Frequently Asked Questions
What is clinical trial NCT00933543 about?
NCT00933543 is a clinical study titled "Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)". The purpose of this trial is to study the efficacy and safety of Visonac PDT in patients from 9 to 35 years old with Aktilite® CL512. Patients was randomized to Visonac or vehicle cream without occlusion and red light(dose: 37J/cm2)
What is the current status of trial NCT00933543?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 107 participants. The study started on 2009-08. Estimated completion is 2010-03.
What conditions does trial NCT00933543 study?
This clinical trial studies the following conditions: Acne Vulgaris.
What interventions are being tested in trial NCT00933543?
The interventions under investigation include: PDT (PROCEDURE), Visonac PDT (MAL PDT) (DRUG), Vehicle cream (placebo) (DRUG).
Who is sponsoring clinical trial NCT00933543?
This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00933543 being conducted?
This trial has 11 study locations across California, Illinois, Minnesota, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
ACTIVE NOT RECRUITING · Phase 2
-
Dose Range Study of CD5789 in Acne Vulgaris
COMPLETED · Phase 2
-
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
COMPLETED · Phase 2
-
Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris
COMPLETED · Phase 2
-
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
COMPLETED · Phase 2
-
A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.